Trial · NCT07798180
Transauricular Neurostimulation for Abdominal Pain Due to DGBI
This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents ag
- Status
- Recruiting
- Sponsor
- Nationwide Children's Hospital
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 30 participants (planned)
- Start
- Oct 23, 2025
- Primary completion
- Oct 30, 2026
- Conditions
- Abdominal Pain (AP), Disorders of Gut-brain Interaction
Summary
This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents aged 12 to 18 years with abdominal pain related to disorders of gut-brain interaction. Up to 30 participants will be enrolled, with a goal of 20 completing the study. Participants will use the device for at least one hour daily for 4 weeks and complete questionnaires through week 8. The study will assess adherence, retention, safety, and preliminary changes in abdominal pain, bowel symptoms, quality of life, and anxiety.
Interventions
- Transcutaneous auricular neurostimulation Device
Locations
1 country: United States.
| Facility | City | Country |
|---|---|---|
| Nationwide Children's Hospital | Columbus, Ohio | United States |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.